Skip to main content

Advertisement

Log in

Prompt Diagnosis and Effective Treatment of Trichosporon asahii Catheter-Related Infection in Non-immunocompromised Neurosurgical Patient

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Trichosporon asahii is a rare but emerging fungal pathogen that causes severe and life-threatening infections with high mortality rate, mostly in immunocompromised patients. It could be easily misdiagnosed due to lack of awareness, especially when invasive or deep-seated infections occur in non-immunocompromised patients, and inadequately treated since the clinical failures and high minimum inhibitory concentrations to some antifungal agents have been described. We present a case of T. asahii catheter-related infection in 66-year-old comatose patient with polytrauma, who was not immunodeficient, but was receiving broad-spectrum antibiotics for a long period. Due to prompt diagnosis and treatment which included catheter replacement and voriconazole, the patient successfully recovered from this infection. The aims of this case report were to highlight the importance of recognizing this otherwise colonizing yeast as potentially dangerous pathogen in non-immunocompromised patients with a long-term antibiotic therapy, and to emphasize the importance of the right therapeutic choice due to its resistance to certain antifungal agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Haupt HM, Merz WG, Beschorner WE, Vaughan WP, Saral R. Colonization and infection with Trichosporon species in the immunosuppressed host. J Infect Dis. 1983;147:199–203.

    Article  CAS  PubMed  Google Scholar 

  2. Chagas-Neto TC, Chaves GM, Columbo AL. Update on genus Trichosporon. Mycopathologia. 2008;166(3):121–32.

    Article  PubMed  Google Scholar 

  3. Gueho E, Improvisi L, de Hoog GS, Dupont B. Trichosporon on humans: a practical account. Mycoses. 1994;37:3–10.

    Article  CAS  PubMed  Google Scholar 

  4. Netsvyetayeva I, Swoboda-Kopec E, Paczek L, Fiedor P, Sikora M, Jaworska-Zaremba M, Blachnio S, Luczak M. Trichosporon asahii as a prospective pathogen in solid organ transplant recipients. Mycoses. 2009;52:263–5.

    Article  CAS  PubMed  Google Scholar 

  5. Dua V, Yadav SP, Oberoi J, Sachdeva A. Successful treatment of Trichosporon asahii infection with voriconazole after bone marrow transplant. J Pediatr Hematol Oncol. 2013;35(3):237–8.

    Article  PubMed  Google Scholar 

  6. Ozkaya-Parlakay A, Karadag-Oncel E, Cengiz AB, Kara A, Yigit A, Gucer S, Gur D. Trichosporon asahii sepsis in a patient with pediatric malignancy. J Microbiol Immunol Infect. 2013 Feb 15. pii: S1684-1182(13)00018-2. doi:10.1016/j.jmii.2013.01.003.

  7. Isenberg HD. Catheter Tip Cultures, in: Clinical Microbiology Procedures Handbook. 2nd edition. Washington, DC: American Society for Microbiology, 2007; 3.6.1–3.6.6.

  8. Ebright JR, Fairfax MR, Vazquez JA. Trichosporon asahii, a non-Candida yeast that caused fatal septic shock in a patient without cancer or neutropenia. Clin Infect Dis. 2001;33(5):E28–30.

    Article  CAS  PubMed  Google Scholar 

  9. Di Bonaventura G, Pompilio A, Picciani C, Iezzi M, D’Antonio D, Piccolomini R. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. Antimicrob Agents Chemother. 2006;50(10):3269–76.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Sun W, Su J, Xu S, Yan D. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing. J Med Microbiol. 2012;61:1750–7.

    Article  CAS  PubMed  Google Scholar 

  11. Clancy CJ, Nquyen MH. Finding the “missing 50 %” of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis. 2013;56(9):1284–92.

    Article  PubMed  Google Scholar 

  12. Rastogi VL, Nirwan PS. Invasive trichosporonosis due to Trichosporon asahii in a non-immunocompromised host: a rare case report. Indian J Med Microbiol. 2007;25(1):59–61.

    Article  CAS  PubMed  Google Scholar 

  13. Kim YJ, Kim SI, Kim YR, Park YM, Park YJ, Kang MW. Successful treatment of septic shock with purpura fulminans caused by Trichosporon asahii in an immunocompetent patient. Ann Clin Lab Sci. 2007;37(4):366–9.

    PubMed  Google Scholar 

  14. Suzuki K, Nakase K, Kyo T, Kohara T, Sugawara Y, Shibazaki T, Oka K, Tsukada T, Katayama N. Fatal Trichosporon fungemia in patients with hematologic malignancies. Eur J Haematol. 2010;84(5):441–7.

    Article  PubMed  Google Scholar 

  15. Shang ST, Yang YS, Peng MY. Nosocomial Trichosporon asahii fungemia in a patient with secondary hemochromatosis: a rare case report. J Microbiol Immunol Infect. 2010;43(1):77–80.

    Article  PubMed  Google Scholar 

  16. Girmenia C, Pagano L, Martino B, D’Antonio D, Fanci R, Specchia G, Melillo L, Buelli M, Pizzarelli G, Venditti M, Martino P. GIMEMA Infection Program. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol. 2005;43(4):1818–28.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Wolf DG, Falk R, Hacham M, Theelen B, Boekhout T, Scorzetti G, Shapiro M, Block C, Salkin IF, Polacheck I. Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units. J Clin Microbiol. 2001;39(12):4420–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Asada N, Uryu H, Koseki M, Takeuchi M, Komatsu M, Matsue K. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia. Clin Infect Dis. 2006;43:e39–41.

    Article  PubMed  Google Scholar 

  19. Matsue K, Uryu H, Koseki M, Asada N, Takeuchi M. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. Clin Infect Dis. 2006;42:753–7.

    Article  CAS  PubMed  Google Scholar 

  20. Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E, Cano V, Tapia C, Perkins A, Gomez-Lopez A, Rodero L, Cuenca-Estrella M. Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother. 2005;49:4026–34.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Bayramoglu G, Sonmez M, Tosun I, Aydin K, Aydin F. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin. Infection. 2008;36:68–70.

    Article  CAS  PubMed  Google Scholar 

  22. ESCMID EFISG study group and ECMM. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect. 2014;20(Suppl 3):76–98.

    Google Scholar 

Download references

Acknowledgments

We thank Dr. Emilija Mlinaric-Missoni from Referral Center for Systemic Mycoses in Croatian Institute of Public Health, Zagreb, for the generous assistance.

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zana Rubic.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rubic, Z., Novak, A., Tomic, Z. et al. Prompt Diagnosis and Effective Treatment of Trichosporon asahii Catheter-Related Infection in Non-immunocompromised Neurosurgical Patient. Mycopathologia 179, 125–128 (2015). https://doi.org/10.1007/s11046-014-9814-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-014-9814-9

Keywords

Navigation